AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, ...

We are thrilled to welcome Craig to the Apellis Board of Directors,” said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. “Craig is a seasoned leader, who has ...

The Notice has no immediate effect on the listing or trading of the Company’s common shares. The Company intends to monitor the bid price of its common shares and consider available options to regain ...

ClinicoEconomics and Outcomes Research is a peer-reviewed healthcare journal focusing on covering the economic impact of health policy and health systems organization. The journal was established in ...

(Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with Silicon ...

The amended merger agreement was unanimously recommended and approved by the disinterested directors of each company’s Board. As previously announced, Stockholders representing approximately 62% of ...

Dr. Mekan brings a combined 18 years of experience in hematology and oncology across academic research, clinical practice and biopharmaceutical industry development, and I am excited to welcome her to ...

The new THCa products were developed to meet growing demand for federally legal, high-purity cannabis alternatives. Boston Hemp formulates all products in alignment with the 2018 Farm Bill and ensures ...

Tributyrin is a type of postbiotic that plays a vital role in maintaining gut health. It helps strengthen the gut barrier, ...

GenF20 Plus is a supplement made with amino acids, peptides and nutrients that help the pituitary gland function better and ...

Mass General Brigham and Saudi healthcare leaders collaborate to redefine the future of healthcare through AI, gene therapy, and venture-backed innovation ...